Mephenytoin

• Catalog No.: DB00532
• CAS Number: 50-12-4
• M. F.: C12H14N2O2
• M. W.: 218.25176

SYNONYMS

• IUPAC name: 5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione
• IUPAC Traditional name: @mephenytoin
• Brand Name: Sedantional; Insulton; Methoin; Triantoin; Epiazin; Gerot-Epilan; Mesdontoin; Mesontoin; Metydan; Phenantoin; Sacerno; Sedantoin; Sedantoinal
• Synonyms: Mephentoin; Methyl Hydantoin; Methylphenetoin

DATABASE IDS

• PubChem CID: 4060
• PubChem SID: 46508677
• CAS Number: 50-12-4

PROPERTIES

• Hydrophobicity(logP): 1.3
• Solubility: 1270 mg/L

DETAILS

Description (English)

• Drug Groups: approved
• Description: Mephenytoin is a hydantoin-derivative anticonvulsant used to control various partial seizures. It is generally reserved for treatment of individuals refractory to less toxic agents. Mephenytoin and oxazolidinedione derivatives are associated with higher incidences of blood dyscrasias compared to other anticonvulsants. As such, these agents should not be used concurrently.
• Indication: For the treatment of refractory partial epilepsy.
• Pharmacology: Mephenytoin is an antiepileptic drug which can be useful in the treatment of epilepsy. The primary site of action appears to be the motor cortex where spread of seizure activity is inhibited. Possibly by promoting sodium efflux from neurons, mephenytoin tends to stabilize the threshold against hyperexcitability caused by excessive stimulation or environmental changes capable of reducing membrane sodium gradient. This includes the reduction of posttetanic potentiation at synapses. Loss of posttetanic potentiation prevents cortical seizure foci from detonating adjacent cortical areas. Mephenytoin reduces the maximal activity of brain stem centers responsible for the tonic phase of tonic-clonic (grand mal) seizures.
• Affected Organisms: Humans and other mammals
• Half Life: Approximately 7 hours
• Distribution: * 1.4 L/kg
• External Links: Wikipedia; Drugs.com